ISPO

Prognostic Indicators II

Gene amplification in primary infiltrating breast cancer and their prognostic value

MH Champeme, I Bieche, K Hacene, R Lidereau

C-myc and c-ha-ras expression as a possible prognostic factor in stomach and lung cancer

I Zborovskaya, N Sukhova, E Ephimova

Accumulation of c-erbB-2 protein correlates with clinical parameters in human colorectal adenocarcinoma

ZP Pavelic MD PhD, R Spaventi MD PhD, S Kapitanovic MD, JL Gluckman MD, K Pavelic MD PhD

The expression of HLA class I antigens in prostate cancer in correlation with tumor differentiation and survival

I Levin, 0. Kuperman, S Segal, T Klein, B Klein

Regulation of breast cancer proliferation by interactions of ligand-dependent and -independent transcription factors

Bart van der Burg, Rivka Slager-Davidov, Bas-jan M van der Leede, Linda Kwakkenbos-Isbrucker, Simone Salverda, Siegfried W de Laat, Paul T van der Saag

Western blotting analysis of cathepsin D in sera and tissues of patients with breast cancer, benign breast disease and normal

JA Alhadeff, D Schultz, L Wright, S Bazel, S Niedbala, MK Lange

Association of c-erbB-2 or c-myc amplification with prognostic indicators in node-negative breast cancer

S Lizard-Nacol PhD, R Lidereau PhD, M Arnal BS, JM Riedinger PhD, L Arnould MD, J Cuisenier MD, J Guerrin MD

Prognostic significance of c-erbB-2 or int-2 gene amplification in human breast cancer

K Kikuchi MD, M Ueda MD, T Ikeda MD, A Suto MD,A Tsuyuki MD, Y Fujishiro MD, K Enomoto MD, M Kitajima MD